{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:30:39Z","timestamp":1776439839931,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0874-3","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T20:16:50Z","timestamp":1427141810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy"],"prefix":"10.1186","volume":"15","author":[{"given":"Nicola","family":"Coppola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Corvino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"De Pascalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Signoriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Nienhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelista","family":"Sagnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Lamberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"874_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0140-6736(05)65598-5","volume":"348","author":"MA Kane","year":"1996","unstructured":"Kane MA. Global status of hepatitis B immunization. Lancet. 1996;348:696.","journal-title":"Lancet"},{"key":"874_CR2","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJM199712113372406","volume":"337","author":"WM Lee","year":"1997","unstructured":"Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733\u201345.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"874_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1386-6532(05)00384-7","volume":"34","author":"D Lavanchy","year":"2005","unstructured":"Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005;34 Suppl 1:S1\u20133.","journal-title":"J Clin Virol"},{"issue":"373","key":"874_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"14","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;14(373):582\u201392.","journal-title":"Lancet"},{"key":"874_CR5","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.3748\/wjg.v20.i24.7635","volume":"20","author":"E Sagnelli","year":"2014","unstructured":"Sagnelli E, Sagnelli C, Pisaturo M, Macera M, Coppola N. Epidemiology acute and chronic hepatitis B and delta over the last 5 decades in Italy. World J Gastroenterol. 2014;20:7635\u201343.","journal-title":"World J Gastroenterol"},{"key":"874_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1086\/524074","volume":"46","author":"E Sagnelli","year":"2008","unstructured":"Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio PL, Italian Hospital Collaborating group. Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. Clin Infect Dis. 2008;46:110\u20133.","journal-title":"Clin Infect Dis"},{"key":"874_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF01641050","volume":"3","author":"F Piccinino","year":"1975","unstructured":"Piccinino F, Manzillo G, Sagnelli E, Balestrieri G, Maio G. Familial clustering of hepatitis B antigen and liver diseases in families with a high incidence of viral hepatitis. Infection. 1975;3:99\u2013104.","journal-title":"Infection"},{"issue":"Suppl.1","key":"874_CR8","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/0264-410X(95)80043-D","volume":"13","author":"P Crovari","year":"1995","unstructured":"Crovari P. Epidemiology of viral hepatitis B in Italy. Vaccine. 1995;13(Suppl1):S26\u201330.","journal-title":"Vaccine"},{"key":"874_CR9","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","volume":"26","author":"AR Zanetti","year":"2008","unstructured":"Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26:6266\u201373.","journal-title":"Vaccine"},{"key":"874_CR10","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/S0140-6736(88)90540-5","volume":"332","author":"M Piazza","year":"1988","unstructured":"Piazza M, Da Villa G, Picciotto L, Abrescia N, Guadagnino V, Memoli AM, et al. Mass vaccination against hepatitis B in infants in Italy. Lancet. 1988;332:1132.","journal-title":"Lancet"},{"key":"874_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0264-410X(93)90222-J","volume":"11","author":"AR Zanetti","year":"1993","unstructured":"Zanetti AR, Tanzi E, Roman\u00f2 L, Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine. 1993;11:521\u20134.","journal-title":"Vaccine"},{"key":"874_CR12","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1016\/j.vaccine.2009.01.056","volume":"26","author":"L Roman\u00f2","year":"2009","unstructured":"Roman\u00f2 L, Paladini S, Tagliacarne C, Zappa A, Zanetti AR. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine. 2009;26:3439\u201342.","journal-title":"Vaccine"},{"key":"874_CR13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(05)67568-X","volume":"366","author":"AR Zanetti","year":"2005","unstructured":"Zanetti AR, Mariano A, Roman\u00f2 L, D\u2019amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005;366:1379\u201384.","journal-title":"Lancet"},{"key":"874_CR14","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1086\/423818","volume":"190","author":"EH Boxall","year":"2004","unstructured":"Boxall EH, Sira JA, El-Shuhkri N, Kelly DA. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis. 2004;190:1264\u20139.","journal-title":"J Infect Dis"},{"key":"874_CR15","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/S0264-410X(01)00005-6","volume":"19","author":"A Faustini","year":"2001","unstructured":"Faustini A, Franco E, Sangalli M, Spadea T, Calabrese RM, Cauletti M, et al. Persistence of anti-HBs 5\u00a0years after the introduction of routine infant and adolescent vaccination in Italy. Vaccine. 2001;19:2812\u20138.","journal-title":"Vaccine"},{"key":"874_CR16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.5812\/kowsar.1735143X.663","volume":"11","author":"M Campagna","year":"2011","unstructured":"Campagna M, Siddu A, Meloni A, Murru C, Masia G, Coppola RC. Epidemiological impact of mandatory vaccination against hepatitis B in italian young adults. Hepat Mon. 2011;11:750\u20132.","journal-title":"Hepat Mon"},{"key":"874_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s15010-011-0233-2","volume":"40","author":"T Stroffolini","year":"2012","unstructured":"Stroffolini T, Guadagnino V, Caroleo B, De Sarro G, Foc\u00e0 A, Liberto MC, et al. Long-term immunogenicity oh hepatitis B vaccination in children and adolescents in a southern Italian town. Infection. 2012;40:299\u2013302.","journal-title":"Infection"},{"key":"874_CR18","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1016\/j.vaccine.2007.01.045","volume":"25","author":"A Gabbuti","year":"2007","unstructured":"Gabbuti A, Roman\u00f2 L, Blanc P, Meacci F, Amendola A, Mele A, et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine. 2007;25:3129\u201332.","journal-title":"Vaccine"},{"key":"874_CR19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/oxfordjournals.epirev.a036023","volume":"10","author":"WA Orenstein","year":"1988","unstructured":"Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev. 1988;10:212\u201341.","journal-title":"Epidemiol Rev"},{"key":"874_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.7326\/0003-4819-142-5-200503010-00008","volume":"142","author":"BJ McMahon","year":"2005","unstructured":"McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-years follow up. Ann Intern Med. 2005;142:333\u201341.","journal-title":"Ann Intern Med"},{"key":"874_CR21","doi-asserted-by":"publisher","first-page":"O680","DOI":"10.1111\/1469-0691.12591","volume":"20","author":"E Spada","year":"2014","unstructured":"Spada E, Roman\u00f2 L, Tosti ME, Zuccaro O, Paladini S, Chironna M, et al. Hepatitis B immunity in teenager. vaccinated as infants: an Italian 17-year follow-up study. Clin Microbiol Infect. 2014;20:O680\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"874_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/INF.0b013e31826f354e","volume":"32","author":"P Teoharov","year":"2013","unstructured":"Teoharov P, Kevorkyan A, Petrova N, Baltadzhiev I, Van Damme P. Immune memory and immune response in children from Bulgaria 5\u201315 years after primary hepatitis B vaccination. Pediatr Infect Dis J. 2013;32:51\u20133.","journal-title":"Pediatr Infect Dis J"},{"key":"874_CR23","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1016\/j.vaccine.2011.07.098","volume":"29","author":"CL Zhu","year":"2011","unstructured":"Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, et al. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination. Vaccine. 2011;29:7835\u201341.","journal-title":"Vaccine"},{"key":"874_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S1473-3099(10)70195-X","volume":"10","author":"AR Zanetti","year":"2010","unstructured":"Zanetti AR, Roman\u00f2 L, Giambi C, Pavan A, Carnelli V, Baitelli G, et al. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study. Lancet Infect Dis. 2010;10:755\u201361.","journal-title":"Lancet Infect Dis"},{"key":"874_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/cid\/ciu867","volume":"60","author":"N Gara","year":"2015","unstructured":"Gara N, Abdalla A, Rivera E, Zhao X, Werner JM, Liang TJ, et al. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. Clin Infect Dis. 2015;60:505\u201313.","journal-title":"Clin Infect Dis"},{"key":"874_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/08830180009088505","volume":"19","author":"CA Siegrist","year":"2000","unstructured":"Siegrist CA. Vaccination in the neonatal period and early infancy. Int Rev Immunol. 2000;19:195\u2013219.","journal-title":"Int Rev Immunol"},{"key":"874_CR27","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S0264-410X(98)00100-5","volume":"16","author":"CA Siegrist","year":"1998","unstructured":"Siegrist CA, Cordova M, Brandt C, Barrios C, Berney M, Tougne C, et al. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine. 1998;16:1409\u201314.","journal-title":"Vaccine"},{"key":"874_CR28","first-page":"211","volume-title":"Wallace\/MaxcyRosenau-last public health and preventive medicine","author":"J Buffington","year":"2007","unstructured":"Buffington J, Mast E. Viral hepatitis. In: Wallace RB, editor. Wallace\/MaxcyRosenau-last public health and preventive medicine. 15th ed. New York: Mc Graw Hill; 2007. p. 211\u201328.","edition":"15"},{"key":"874_CR29","unstructured":"Dlgs 9\/4\/2008, n. 81. Testo unico sulla salute e sicurezza al lavoro. G.U. n.101 30\/04\/2008 \u2013Supplemento Ordinario n.108: \n                    http:\/\/www.gazzettaufficiale.it\/eli\/id\/2008\/04\/30\/008G0104\/sg"},{"key":"874_CR30","first-page":"191","volume":"2","author":"M Askarian","year":"2011","unstructured":"Askarian M, Yadollahi M, Kuochak F, Danaei M, Vakili V, Momeni M. Precautions for health care workers to avoid hepatitis B and C virus infection. Int J Occup Environ Med. 2011;2:191\u20138.","journal-title":"Int J Occup Environ Med"},{"key":"874_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/jorc.12050","volume":"40","author":"MM Elseviers","year":"2014","unstructured":"Elseviers MM, Arias-Guill\u00e9n M, Gorke A, Arens HJ. Sharps injuries amongst healthcare workers: review of incidence, transmissions and costs. J Ren Care. 2014;40:150\u20136.","journal-title":"J Ren Care"},{"key":"874_CR32","first-page":"1","volume":"46","author":"Centers for Disease Control and Prevention (CDC)","year":"1997","unstructured":"Centers for Disease Control and Prevention (CDC). Immunization of healthcare workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR. 1997;46:1\u201342.","journal-title":"MMWR"},{"issue":"355","key":"874_CR33","first-page":"561","volume":"5","author":"European Consensus Group on Hepatitis B Immunity","year":"2000","unstructured":"European Consensus Group on Hepatitis B Immunity. Consensus statement. Are booster immunizations needed for lifelong hepatitis B immunity? Lancet. 2000;5(355):561\u20135.","journal-title":"Lancet"},{"key":"874_CR34","volume-title":"Occupational Safety and Health Administration. Enforcement procedures for the occupational exposure to bloodborne pathogens. Directive N\u00b0 CPL 2\u20132.69; Standard N\u00b0 1910.1030","author":"OSHA","year":"2001","unstructured":"OSHA. Occupational Safety and Health Administration. Enforcement procedures for the occupational exposure to bloodborne pathogens. Directive N\u00b0 CPL 2\u20132.69; Standard N\u00b0 1910.1030. Washington DS, USA: Office of Health Compliance Assistence; 2001."},{"key":"874_CR35","volume-title":"Linee Guida SIMLII per la sorveglianza sanitaria dei lavoratori della sanit\u00e0 esposti a rischio biologico","author":"L Alessio","year":"2005","unstructured":"Alessio L, Porru S, Longo F. Linee Guida SIMLII per la sorveglianza sanitaria dei lavoratori della sanit\u00e0 esposti a rischio biologico. Pavia: PI-ME Ed; 2005."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0874-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0874-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0874-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0874-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:44:06Z","timestamp":1551167046000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0874-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["874"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0874-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]},"assertion":[{"value":"21 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"149"}}